2-piperidone has been researched along with Hemorrhagic Shock in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, V; Houson, H; Nkepang, G; Rao, G; Teng, C; Yari, H | 1 |
| Awasthi, V; Roberts, PR; Sahoo, K; Yadav, VR | 1 |
| Awasthi, S; Awasthi, V; Vilekar, P; Yadav, VR | 1 |
| Awasthi, V; Hussain, A; Sahoo, K; Yadav, VR | 1 |
| Awasthi, V; Hussain, A; Kosanke, S; Xie, J; Yadav, VR | 1 |
| Awasthi, V; Hedrick, A; Rao, G; Xie, J | 1 |
6 other study(ies) available for 2-piperidone and Hemorrhagic Shock
| Article | Year |
|---|---|
Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24.
Topics: Animals; Anti-Inflammatory Agents; Benzylidene Compounds; Intestinal Mucosa; Intestine, Small; Multiple Organ Failure; Piperidones; Proteasome Endopeptidase Complex; Rats; Shock, Hemorrhagic; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2018 |
Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival.
Topics: Animals; Anti-Inflammatory Agents; Benzylidene Compounds; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Heme Oxygenase (Decyclizing); Hypovolemia; Lung; Male; Nitric Oxide Synthase Type II; Piperidones; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Survival Analysis; Transcription Factor RelA | 2013 |
Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock.
Topics: Animals; Benzylidene Compounds; Disease Models, Animal; Lung; Male; NF-kappa B; Piperidones; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1; Shock, Hemorrhagic; Signal Transduction; Toll-Like Receptor 4 | 2014 |
Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzylidene Compounds; Epithelial Cells; Ileum; Intestinal Mucosa; Male; Permeability; Peroxidase; Piperidones; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Shock, Hemorrhagic; Tight Junction Proteins | 2014 |
The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model.
Topics: Animals; Benzylidene Compounds; Disease Models, Animal; Immunoblotting; Immunohistochemistry; Liver; Piperidones; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2015 |
Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model.
Topics: Adenosine Triphosphate; Animals; Benzylidene Compounds; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Energy Metabolism; Male; Mitochondria; NAD; Nerve Growth Factor; Neuroprotective Agents; Phosphocreatine; Piperidones; Pyruvic Acid; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2015 |